Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Conditions
Interventions
Intervention1: Intervention Group: Home based multimodal Prehabilitation program: Participants in this group will receive a home-based multimodal prehabilitation program
designed to support them thro
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: 1 Neoadjuvant chemotherapy followed by interval cytoreductive surgery. 2 Above 18 years 3 ECOG Performance Score of 0-3
Exclusion criteria
Exclusion criteria: 1 Pre-existing inflammatory disorders such as major infections, burns, open wounds, fistulas, acute trauma, chronic organ diseases like congestive heart failure, rheumatoid arthritis, chronic kidney or liver disease, or AIDS. 2 Pre-diagnosed myopathy, malabsorption syndromes, recent pulse steroid therapy or major surgery within the past 30 days, a final pathological diagnosis of benign disease, planned primary cytoreduction for newly diagnosed epithelial ovarian cancer (EOC), recurrent ovarian cancer, non-epithelial ovarian malignancies, or those undergoing palliative care.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in malnutrition scores before and after the prehabilitation program will be compared between experimental and control groups, along with adherence assessment in the experimental arm. Short-term surgical outcomes—including hospital stay, blood loss, transfusion needs, and 30-day complications (Clavien-Dindo classification)—will also be analyzedTimepoint: An 8-week home-based prehabilitation program starting after the first chemotherapy cycle will evaluate its effects on clinical, nutritional, and functional outcomes. | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr Seema Singhal
All India Institute of Medical Sciences New Delhi
Outcome results
None listed